Skip to content

BDX vs JNJ: Dividend Comparison

BDX$177.39
Becton Dickinson & Co
Health Care
vs
JNJ$243.53
Johnson & Johnson
Health Care

Dividend data as of

Becton Dickinson & Co (BDX) and Johnson & Johnson (JNJ) are both in the Health Care sector, making them natural rivals for dividend investors. Both stocks offer similar yields — BDX at 2.36% and JNJ at 2.16%. Both stocks show similar dividend growth rates, each around 6.2% over the past five years. JNJ holds the edge in dividend safety with a "Safe" rating. BDX is a Dividend Aristocrat while JNJ is a Dividend King.

Verdict

Best for Income
BDX
Higher yield at 2.36%
Best for Growth
BDX
5yr CAGR of 6.2%
Best for Safety
JNJ
Rated "Safe"
Metric
Price
$177.39
$243.53
Dividend Yield
2.36%
2.16%
Annual Dividend
$4.20
$5.14
5yr Div CAGR
6.2%
5.2%
3yr Div CAGR
6.5%
4.6%
Consecutive Years
43
63
Payout Ratio
68.14%
46.60%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$236/yr
$216/yr

Yield Analysis

BDX
2.36%
JNJ
2.16%

BDX yields 0.20% more than JNJ. In dollar terms, BDX pays $4.20/share vs JNJ's $5.14/share annually.

Dividend Growth

BDX 5yr CAGR
6.2%
steady
JNJ 5yr CAGR
5.2%
decelerating

BDX: Dividend growth has been steady, with a 3-year CAGR of 6.5% and a 5-year CAGR of 6.2% (10-year: 5.2%).

JNJ: Dividend growth is slowing — the 3-year CAGR of 4.6% trails the 5-year rate of 5.2% and the 10-year rate of 5.6%.

Dividend Safety

BDX
Moderate
Payout Ratio68%
JNJ
Safe
Payout Ratio47%

BDX: The payout ratio of 68% is moderate. The dividend is currently covered by earnings but leaves less room for growth. Earnings cover the dividend 1.5x.

JNJ: The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
BDX
JNJ
$10,000
$236/yr
$216/yr
$50,000
$1,180/yr
$1,078/yr
$100,000
$2,360/yr
$2,156/yr

What does $10,000 buy in BDX vs JNJ today?

At $177.39 per share, $10,000 buys about 56.4 shares of Becton Dickinson & Co (BDX). Each share pays $4.20 per year in dividends, so the position starts out generating roughly $237 per year — about $20 a month.

At $243.53 per share, $10,000 buys about 41.1 shares of Johnson & Johnson (JNJ). Each share pays $5.14 per year in dividends, so the position starts out generating roughly $211 per year — about $18 a month.

BDX is the larger income stream from day one: $26 per year more on the same $10,000 invested.

What could $10,000 of BDX or JNJ income look like in 10 years?

Becton Dickinson & Co (BDX) has raised its dividend about 6.2% a year over the past five years. If that pace held, the $236 per year that $10,000 generates today at the current 2.36% yield would reach $431 per year by 2036 — a 4.3% yield on the original cost.

Johnson & Johnson (JNJ) has raised its dividend about 5.2% a year over the past five years. If that pace held, the $216 per year that $10,000 generates today at the current 2.16% yield would reach $359 per year by 2036 — a 3.6% yield on the original cost.

On those trailing rates, BDX pays more in 2036: $431 versus $359 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would JNJ's dividend growth overtake BDX's higher yield?

It doesn't, on the trailing numbers. Becton Dickinson & Co (BDX) yields more today (2.36% vs 2.16%) and has also grown its dividend at least as fast (6.2% vs 5.2% a year over five years). Unless JNJ accelerates its raises or BDX stumbles, JNJ never closes the income gap — BDX wins on both current income and growth.

Can BDX and JNJ afford their dividends?

Becton Dickinson & Co (BDX) earns $6.12 per share against $4.20 paid out in dividends — 1.5x coverage (a 68% payout ratio).

Johnson & Johnson (JNJ) earns $11.03 per share against $5.14 paid out in dividends — 2.1x coverage (a 47% payout ratio).

JNJ's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for BDX if earnings weaken.

Which fits an early-retirement income portfolio better, BDX or JNJ?

For income you need right now, Becton Dickinson & Co (BDX) leads: $100,000 invested today pays about $197 a month at the current 2.36% yield, versus $180 a month from Johnson & Johnson (JNJ) at 2.16%.

BDX also leads on dividend growth (6.2% vs 5.2% a year over five years), so the trailing numbers favor it on both fronts.

On consistency: BDX has raised its dividend 43 consecutive years; JNJ has raised its dividend 63 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $544/yr in BDX vs $445/yr in JNJ by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Track BDX and JNJ in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan.

Choosing a tracker? See the best dividend trackers compared.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.